"Herpes Zoster Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An attenuated vaccine used to prevent and/or treat HERPES ZOSTER, a disease caused by HUMAN HERPESVIRUS 3.
MeSH Number(s)
D20.215.894.899.290.130.400
Concept/Terms
Herpes Zoster Vaccine- Herpes Zoster Vaccine
- Vaccine, Herpes Zoster
- Zoster Vaccine
- Vaccine, Zoster
- Shingles Vaccine
- Vaccine, Shingles
Below are MeSH descriptors whose meaning is more general than "Herpes Zoster Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Herpes Zoster Vaccine".
This graph shows the total number of publications written about "Herpes Zoster Vaccine" by people in Harvard Catalyst Profiles by year, and whether "Herpes Zoster Vaccine" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 2 | 0 | 2 |
2008 | 1 | 1 | 2 |
2009 | 1 | 0 | 1 |
2010 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2013 | 3 | 0 | 3 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 1 | 1 | 2 |
2018 | 1 | 1 | 2 |
2019 | 4 | 1 | 5 |
2021 | 3 | 0 | 3 |
2022 | 4 | 0 | 4 |
2023 | 2 | 0 | 2 |
2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Herpes Zoster Vaccine" by people in Profiles.
-
Herpes zoster mRNA vaccine induces superior vaccine immunity over licensed vaccine in mice and rhesus macaques. Emerg Microbes Infect. 2024 Dec; 13(1):2309985.
-
Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for Escherichia coli-based vaccine design. Sci China Life Sci. 2023 04; 66(4):743-753.
-
Sequential Data-Mining for Adverse Events After Recombinant Herpes Zoster Vaccination Using the Tree-Based Scan Statistic. Am J Epidemiol. 2023 02 01; 192(2):276-282.
-
Baculovirus Display of Varicella-Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice. Viruses. 2022 08 16; 14(8).
-
Projected risks and health benefits of vaccination against herpes zoster and related complications in US adults. Hum Vaccin Immunother. 2022 11 30; 18(5):2060668.
-
A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine. Am J Epidemiol. 2022 03 24; 191(5):957-964.
-
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL. Blood Adv. 2022 03 22; 6(6):1732-1740.
-
Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged =19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jan 21; 71(3):80-84.
-
Influenza Vaccine Uptake in the Year After Concurrent vs Separate Influenza and Zoster Immunization. JAMA Netw Open. 2021 11 01; 4(11):e2135362.
-
Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation. Blood Adv. 2021 03 23; 5(6):1585-1593.